Kaplan Meier survival curve for NSCLC patients stratified by PLR systemic inflammation, PLR < 185 and PLR ≥ 185 (n = 184), showing worse survival probability (p = 0.005) for patients having greater inflammation (i.e., above PLR cutoff).</p
<p>Kaplan-Meier survival curves for patients with (N = 19; median survival 96 months) or without (N ...
<p>Kaplan-Meier estimates of survival curves for patients with advanced lung cancer stratified into ...
A: Kaplan-Meier survival curve for major adverse cardiovascular events (MACE: cardiovascular death, ...
Kaplan Meier survival curve for NSCLC patients stratified by NLR systemic inflammation, NLR < 5 and ...
Kaplan Meier survival curve for NSCLC patients stratified by ALI systemic inflammation, ALI < 24 and...
<p><i>P</i> values were determined by the log-rank test. (A) Distant recurrence-free survival, (B) d...
<p>Disease-free survival (A) and Overall survival (B) for low NPAA and high NPAA patients. P values ...
<p>The patients were stratified into two groups based on the median of the T cell proportion among t...
Kaplan–Meier curves for overall survival stratified by NLR levels (A), PLR (B), CEA levels (C), CA 1...
<p>Kaplan-Meier analysis to plot the survival curve of all 272 NPC patients with expression of p-Mnk...
<p>Kaplan Meier survival curve for tumour peripheral (TP) polo-like kinase 1 (PLK1) weighted scores....
<p>Kaplan-Meier overall survival curves for NSTE-ACS patients according to normal and low LVEF.</p
<p>The overall survival of patients with NK-AML (solid line) and CK-AML (dotted line) analyzed by th...
<p>Kaplan-Meier survival curve for male advanced NSCLC patients by <i>BCL2</i> rs1564483 G>A genotyp...
<p>Kaplan-Meier survival curves according to preoperative NT-pro-BNP and cTnI levels</p
<p>Kaplan-Meier survival curves for patients with (N = 19; median survival 96 months) or without (N ...
<p>Kaplan-Meier estimates of survival curves for patients with advanced lung cancer stratified into ...
A: Kaplan-Meier survival curve for major adverse cardiovascular events (MACE: cardiovascular death, ...
Kaplan Meier survival curve for NSCLC patients stratified by NLR systemic inflammation, NLR < 5 and ...
Kaplan Meier survival curve for NSCLC patients stratified by ALI systemic inflammation, ALI < 24 and...
<p><i>P</i> values were determined by the log-rank test. (A) Distant recurrence-free survival, (B) d...
<p>Disease-free survival (A) and Overall survival (B) for low NPAA and high NPAA patients. P values ...
<p>The patients were stratified into two groups based on the median of the T cell proportion among t...
Kaplan–Meier curves for overall survival stratified by NLR levels (A), PLR (B), CEA levels (C), CA 1...
<p>Kaplan-Meier analysis to plot the survival curve of all 272 NPC patients with expression of p-Mnk...
<p>Kaplan Meier survival curve for tumour peripheral (TP) polo-like kinase 1 (PLK1) weighted scores....
<p>Kaplan-Meier overall survival curves for NSTE-ACS patients according to normal and low LVEF.</p
<p>The overall survival of patients with NK-AML (solid line) and CK-AML (dotted line) analyzed by th...
<p>Kaplan-Meier survival curve for male advanced NSCLC patients by <i>BCL2</i> rs1564483 G>A genotyp...
<p>Kaplan-Meier survival curves according to preoperative NT-pro-BNP and cTnI levels</p
<p>Kaplan-Meier survival curves for patients with (N = 19; median survival 96 months) or without (N ...
<p>Kaplan-Meier estimates of survival curves for patients with advanced lung cancer stratified into ...
A: Kaplan-Meier survival curve for major adverse cardiovascular events (MACE: cardiovascular death, ...